한글목차

DNA 프로브 기반 진단 세계 시장은 2030년까지 미국에서 345억 달러에 달할 전망

2023년에 183억 달러로 추정되는 DNA 프로브 기반 진단 세계 시장은 2023-2030년간 CAGR 9.5%로 성장하고, 2030년에는 345억 달러에 이를 것으로 예측됩니다. 이 보고서에서 분석한 부문 중 하나인 감염 애플리케이션은 CAGR 9.3%로 성장을 지속하고, 분석 기간이 끝날 때 204억 달러에 도달할 것으로 예측됩니다. 암 응용 분야의 성장률은 분석 기간 중 CAGR 10.4%로 추정됩니다.

미국 시장은 49억 달러로 추정, 중국은 CAGR 8.9%로 성장 예측

미국 DNA 프로브 기반 진단 시장은 2023년 49억 달러로 추정됩니다. 세계 2위 경제대국인 중국은 2030년까지 54억 달러 규모에 이를 것으로 예측되며, 분석 기간 2023-2030년의 CAGR은 8.9%입니다. 기타 주목할 만한 지역별 시장으로는 일본과 캐나다가 있으며, 분석 기간 중 CAGR은 각각 8.5%와 7.9%로 예측되고 있습니다. 유럽에서는 독일이 CAGR 약 7.4%로 성장할 것으로 예측됩니다.

세계 DNA 프로브 기반 진단 시장 - 주요 동향과 촉진요인 요약

DNA 프로브 기반 진단은 병원체와 유전자 변이를 확인하는데 있어서 매우 중요하고, 세계의 감염증 증가에 대처하고, 개별화 헬스 케어를 진행하는데 있어서 매우 중요합니다. 실시간 PCR 및 차세대 시퀀싱과 같은 유전체 시퀀싱 및 분석의 기술적 진보는 DNA 프로브 기반 진단 속도와 정확성을 향상시키고 시장 성장을 가속합니다. 맞춤형 의료는 개인의 유전 정보에 기초한 맞춤형 치료 전략이 요구되고 있으며, 특히 감염증 진단에서는 그 편리성과 신속한 결과가 평가되고 가정용 DNA 진단 기술이 각광받고 있습니다.

DNA 프로브 기반 진단은 다양한 약물에 대한 개인의 반응에 영향을 미치는 유전자 변이를 확인하는데 중요한 역할을 하며, 이에 따라 맞춤형 치료 전략이 가능해집니다. 홈 기반 DNA 진단 기술을 향한 움직임은 개인화되고 사용하기 쉬운 건강 관리를 향한 광범위한 동향의 일부입니다. 자기 샘플 준비, 등온 증폭, LFA에 머무르지 않고, 자동 샘플 준비를 위한 마이크로플루이딕스 공학, 소형 장치를 위한 소형화 PCR, DNA로부터의 전기 신호를 측정하는 전기 화학적 검출법 등의 개발에 의해 업계 혁신을 계속하고 있습니다. 이러한 기술은 가정에서 진단의 간편성과 효능을 향상시킬 뿐만 아니라 소비자 기반 신속한 질병 모니터링 및 직접 관리를 위한 새로운 길을 열 것으로 예상됩니다.

DNA 프로브 기반 진단 시장은 기술의 진보, 헬스케어 요구의 증대, 맞춤형 의료의 중시의 고조에 의해 크게 성장할 전망입니다. 이러한 진단이 디지털 기술과 통합되어 새로운 의료 분야로 확장됨에 따라 무수한 의료 진단 및 치료 속도와 정확성을 향상시켜 세계 건강 관리 제공의 핵심 존재가 될 가능성이 높습니다. 디지털 기술과 모바일 기술과의 통합은 DNA 프로브를 통한 진단의 접근성을 확대하여 기존 실험실 환경 이외의 원격 데이터 분석 및 실시간 모니터링을 가능하게 합니다. 하나의 샘플에서 여러 병원체와 유전자 변화를 검출할 수 있는 멀티플렉스 검사는 유행성 발생과 복잡한 유전자 검사의 효율을 높입니다. 자동화 및 높은 처리량 시스템은 대규모 역학 연구 및 임상시험에 필수적인 진단 효율성을 높이는 동시에 실험실에서 인적 실수의 가능성을 줄입니다.

조사 대상 기업 예(주목의 46사)

• Abbott Molecular
• Beckman Coulter Inc.
• Becton, Dickinson and Company
• bioMerieux
• F. Hoffmann-La Roche Ltd.
• GE Healthcare Life Sciences
• Luminex Corporation
• QIAGEN NV
• Siemens Healthineers
• Thermo Fischer Scientific Inc.

목차

제1장 조사 방법

제2장 주요 요약

• 시장 개요
• 주요 기업
• 시장 동향과 촉진요인
• 세계 시장 전망

제3장 시장 분석

• 미국
• 캐나다
• 일본
• 중국
• 유럽
• 프랑스
• 독일
• 이탈리아
• 영국
• 기타 유럽
• 아시아태평양
• 세계 기타 지역

제4장 경쟁

영문목차

Global DNA Probes-Based Diagnostics Market to Reach US$34.5 Billion by 2030

The global market for DNA Probes-Based Diagnostics estimated at US$18.3 Billion in the year 2023, is expected to reach US$34.5 Billion by 2030, growing at a CAGR of 9.5% over the analysis period 2023-2030. Infectious Diseases Application, one of the segments analyzed in the report, is expected to record a 9.3% CAGR and reach US$20.4 Billion by the end of the analysis period. Growth in the Cancer Application segment is estimated at 10.4% CAGR over the analysis period.

The U.S. Market is Estimated at US$4.9 Billion While China is Forecast to Grow at 8.9% CAGR

The DNA Probes-Based Diagnostics market in the U.S. is estimated at US$4.9 Billion in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$5.4 Billion by the year 2030 trailing a CAGR of 8.9% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 8.5% and 7.9% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 7.4% CAGR.

Global DNA Probes-Based Diagnostics Market - Key Trends and Drivers Summarized

DNA probes-based diagnostics are pivotal in identifying pathogens, genetic mutations, crucial for addressing the global increase in infectious diseases and advancing personalized healthcare. Technological advancements in genomic sequencing and analysis, such as real-time PCR and next-generation sequencing, enhance the speed and accuracy of DNA probes-based diagnostics, driving market growth. Personalized medicine demands tailored therapeutic strategies based on individual genetic information, with home-based DNA diagnostic technologies gaining prominence for their convenience and rapid results, particularly in infectious disease diagnosis.

DNA probes-based diagnostics play a critical role in identifying genetic variations that affect individual responses to different medications, thus enabling tailored therapeutic strategies. The push towards home-based DNA diagnostic technologies is part of a broader trend towards personalized and accessible healthcare. Beyond magnetic sample preparation, isothermal amplification, and LFAs, the industry continues to innovate with developments in microfluidics for automated sample preparation, miniaturized PCR for compact devices, and electrochemical detection methods that measure electrical signals from DNA. These technologies not only promise to enhance the ease and effectiveness of home diagnostics but also open new avenues for rapid disease monitoring and management directly by consumers.

The market for DNA probes-based diagnostics is poised for significant growth, driven by technological advancements, increased healthcare needs, and the rising emphasis on personalized medicine. As these diagnostics become more integrated with digital technologies and expand into new medical fields, they will likely become even more central to healthcare delivery worldwide, improving the speed and accuracy of myriad medical diagnostics and treatments. Integration with digital and mobile technologies expands the accessibility of DNA probes-based diagnostics, enabling remote data analysis and real-time monitoring outside traditional lab settings. Multiplex testing, capable of detecting multiple pathogens or genetic changes from a single sample, enhances efficiency in pandemic outbreaks and complex genetic testing. Automation and high-throughput systems increase diagnostic efficiency, essential for large-scale epidemiological studies and clinical trials, while reducing human error potential in laboratories.

Select Competitors (Total 46 Featured) -

• Abbott Molecular
• Beckman Coulter Inc.
• Becton, Dickinson and Company
• bioMerieux
• F. Hoffmann-La Roche Ltd.
• GE Healthcare Life Sciences
• Luminex Corporation
• QIAGEN N.V.
• Siemens Healthineers
• Thermo Fischer Scientific Inc.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

• 1. MARKET OVERVIEW
  • Influencer Market Insights
  • Global Economic Update
  • DNA Probes-Based Diagnostics - Global Key Competitors Percentage Market Share in 2024 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
• 2. FOCUS ON SELECT PLAYERS
• 3. MARKET TRENDS & DRIVERS
  • Rising Incidence of Genetic Disorders Strengthens Business Case for DNA Probes-Based Diagnostics
  • Growing Awareness of the Benefits of Early and Accurate Diagnosis Drives Adoption Across Various Medical Fields
  • Advances in Genomic Technologies Propel Growth of DNA Probes-Based Diagnostics Market
  • Increasing Adoption of Personalized Medicine Expands Addressable Market Opportunity for DNA Probes-Based Diagnostics
  • Growth in Infectious Disease Testing Generates Demand for Rapid DNA Probe-Based Diagnostic Solutions
  • Expansion of Point-of-Care Testing Sustains Growth in DNA Probes-Based Diagnostics Market
  • Integration of AI and Machine Learning in Diagnostics Enhances Accuracy and Efficiency
  • Focus on Genomic Research Generates Opportunities for Innovation in DNA Probes-Based Diagnostics
  • Growth in Cancer Screening Drives Use of DNA Probes-Based Diagnostic Tests
  • Adoption of DNA Probes-Based Diagnostics in Prenatal Testing Expands Addressable Market Opportunity
• 4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World DNA Probes-Based Diagnostics Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
  • TABLE 2: World Recent Past, Current & Future Analysis for DNA Probes-Based Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • TABLE 3: World Historic Review for DNA Probes-Based Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 4: World 16-Year Perspective for DNA Probes-Based Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2024 & 2030
  • TABLE 5: World Recent Past, Current & Future Analysis for Infectious Diseases by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • TABLE 6: World Historic Review for Infectious Diseases by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 7: World 16-Year Perspective for Infectious Diseases by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
  • TABLE 8: World Recent Past, Current & Future Analysis for Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • TABLE 9: World Historic Review for Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 10: World 16-Year Perspective for Cancer by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
  • TABLE 11: World Recent Past, Current & Future Analysis for Genetic Predisposition by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • TABLE 12: World Historic Review for Genetic Predisposition by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 13: World 16-Year Perspective for Genetic Predisposition by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
  • TABLE 14: World Recent Past, Current & Future Analysis for Identity / Forensics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • TABLE 15: World Historic Review for Identity / Forensics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 16: World 16-Year Perspective for Identity / Forensics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
  • TABLE 17: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • TABLE 18: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 19: World 16-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

• UNITED STATES
  • DNA Probes-Based Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
  • TABLE 20: USA Recent Past, Current & Future Analysis for DNA Probes-Based Diagnostics by Application - Infectious Diseases, Cancer, Genetic Predisposition, Identity / Forensics and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 21: USA Historic Review for DNA Probes-Based Diagnostics by Application - Infectious Diseases, Cancer, Genetic Predisposition, Identity / Forensics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 22: USA 16-Year Perspective for DNA Probes-Based Diagnostics by Application - Percentage Breakdown of Value Sales for Infectious Diseases, Cancer, Genetic Predisposition, Identity / Forensics and Other Applications for the Years 2014, 2024 & 2030
• CANADA
  • TABLE 23: Canada Recent Past, Current & Future Analysis for DNA Probes-Based Diagnostics by Application - Infectious Diseases, Cancer, Genetic Predisposition, Identity / Forensics and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 24: Canada Historic Review for DNA Probes-Based Diagnostics by Application - Infectious Diseases, Cancer, Genetic Predisposition, Identity / Forensics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 25: Canada 16-Year Perspective for DNA Probes-Based Diagnostics by Application - Percentage Breakdown of Value Sales for Infectious Diseases, Cancer, Genetic Predisposition, Identity / Forensics and Other Applications for the Years 2014, 2024 & 2030
• JAPAN
  • DNA Probes-Based Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
  • TABLE 26: Japan Recent Past, Current & Future Analysis for DNA Probes-Based Diagnostics by Application - Infectious Diseases, Cancer, Genetic Predisposition, Identity / Forensics and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 27: Japan Historic Review for DNA Probes-Based Diagnostics by Application - Infectious Diseases, Cancer, Genetic Predisposition, Identity / Forensics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 28: Japan 16-Year Perspective for DNA Probes-Based Diagnostics by Application - Percentage Breakdown of Value Sales for Infectious Diseases, Cancer, Genetic Predisposition, Identity / Forensics and Other Applications for the Years 2014, 2024 & 2030
• CHINA
  • DNA Probes-Based Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
  • TABLE 29: China Recent Past, Current & Future Analysis for DNA Probes-Based Diagnostics by Application - Infectious Diseases, Cancer, Genetic Predisposition, Identity / Forensics and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 30: China Historic Review for DNA Probes-Based Diagnostics by Application - Infectious Diseases, Cancer, Genetic Predisposition, Identity / Forensics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 31: China 16-Year Perspective for DNA Probes-Based Diagnostics by Application - Percentage Breakdown of Value Sales for Infectious Diseases, Cancer, Genetic Predisposition, Identity / Forensics and Other Applications for the Years 2014, 2024 & 2030
• EUROPE
  • DNA Probes-Based Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
  • TABLE 32: Europe Recent Past, Current & Future Analysis for DNA Probes-Based Diagnostics by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • TABLE 33: Europe Historic Review for DNA Probes-Based Diagnostics by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 34: Europe 16-Year Perspective for DNA Probes-Based Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2014, 2024 & 2030
  • TABLE 35: Europe Recent Past, Current & Future Analysis for DNA Probes-Based Diagnostics by Application - Infectious Diseases, Cancer, Genetic Predisposition, Identity / Forensics and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 36: Europe Historic Review for DNA Probes-Based Diagnostics by Application - Infectious Diseases, Cancer, Genetic Predisposition, Identity / Forensics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 37: Europe 16-Year Perspective for DNA Probes-Based Diagnostics by Application - Percentage Breakdown of Value Sales for Infectious Diseases, Cancer, Genetic Predisposition, Identity / Forensics and Other Applications for the Years 2014, 2024 & 2030
• FRANCE
  • DNA Probes-Based Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
  • TABLE 38: France Recent Past, Current & Future Analysis for DNA Probes-Based Diagnostics by Application - Infectious Diseases, Cancer, Genetic Predisposition, Identity / Forensics and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 39: France Historic Review for DNA Probes-Based Diagnostics by Application - Infectious Diseases, Cancer, Genetic Predisposition, Identity / Forensics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 40: France 16-Year Perspective for DNA Probes-Based Diagnostics by Application - Percentage Breakdown of Value Sales for Infectious Diseases, Cancer, Genetic Predisposition, Identity / Forensics and Other Applications for the Years 2014, 2024 & 2030
• GERMANY
  • DNA Probes-Based Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
  • TABLE 41: Germany Recent Past, Current & Future Analysis for DNA Probes-Based Diagnostics by Application - Infectious Diseases, Cancer, Genetic Predisposition, Identity / Forensics and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 42: Germany Historic Review for DNA Probes-Based Diagnostics by Application - Infectious Diseases, Cancer, Genetic Predisposition, Identity / Forensics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 43: Germany 16-Year Perspective for DNA Probes-Based Diagnostics by Application - Percentage Breakdown of Value Sales for Infectious Diseases, Cancer, Genetic Predisposition, Identity / Forensics and Other Applications for the Years 2014, 2024 & 2030
• ITALY
  • TABLE 44: Italy Recent Past, Current & Future Analysis for DNA Probes-Based Diagnostics by Application - Infectious Diseases, Cancer, Genetic Predisposition, Identity / Forensics and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 45: Italy Historic Review for DNA Probes-Based Diagnostics by Application - Infectious Diseases, Cancer, Genetic Predisposition, Identity / Forensics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 46: Italy 16-Year Perspective for DNA Probes-Based Diagnostics by Application - Percentage Breakdown of Value Sales for Infectious Diseases, Cancer, Genetic Predisposition, Identity / Forensics and Other Applications for the Years 2014, 2024 & 2030
• UNITED KINGDOM
  • DNA Probes-Based Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
  • TABLE 47: UK Recent Past, Current & Future Analysis for DNA Probes-Based Diagnostics by Application - Infectious Diseases, Cancer, Genetic Predisposition, Identity / Forensics and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 48: UK Historic Review for DNA Probes-Based Diagnostics by Application - Infectious Diseases, Cancer, Genetic Predisposition, Identity / Forensics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 49: UK 16-Year Perspective for DNA Probes-Based Diagnostics by Application - Percentage Breakdown of Value Sales for Infectious Diseases, Cancer, Genetic Predisposition, Identity / Forensics and Other Applications for the Years 2014, 2024 & 2030
• REST OF EUROPE
  • TABLE 50: Rest of Europe Recent Past, Current & Future Analysis for DNA Probes-Based Diagnostics by Application - Infectious Diseases, Cancer, Genetic Predisposition, Identity / Forensics and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 51: Rest of Europe Historic Review for DNA Probes-Based Diagnostics by Application - Infectious Diseases, Cancer, Genetic Predisposition, Identity / Forensics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 52: Rest of Europe 16-Year Perspective for DNA Probes-Based Diagnostics by Application - Percentage Breakdown of Value Sales for Infectious Diseases, Cancer, Genetic Predisposition, Identity / Forensics and Other Applications for the Years 2014, 2024 & 2030
• ASIA-PACIFIC
  • DNA Probes-Based Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
  • TABLE 53: Asia-Pacific Recent Past, Current & Future Analysis for DNA Probes-Based Diagnostics by Application - Infectious Diseases, Cancer, Genetic Predisposition, Identity / Forensics and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 54: Asia-Pacific Historic Review for DNA Probes-Based Diagnostics by Application - Infectious Diseases, Cancer, Genetic Predisposition, Identity / Forensics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 55: Asia-Pacific 16-Year Perspective for DNA Probes-Based Diagnostics by Application - Percentage Breakdown of Value Sales for Infectious Diseases, Cancer, Genetic Predisposition, Identity / Forensics and Other Applications for the Years 2014, 2024 & 2030
• REST OF WORLD
  • TABLE 56: Rest of World Recent Past, Current & Future Analysis for DNA Probes-Based Diagnostics by Application - Infectious Diseases, Cancer, Genetic Predisposition, Identity / Forensics and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 57: Rest of World Historic Review for DNA Probes-Based Diagnostics by Application - Infectious Diseases, Cancer, Genetic Predisposition, Identity / Forensics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 58: Rest of World 16-Year Perspective for DNA Probes-Based Diagnostics by Application - Percentage Breakdown of Value Sales for Infectious Diseases, Cancer, Genetic Predisposition, Identity / Forensics and Other Applications for the Years 2014, 2024 & 2030

IV. COMPETITION